NCT02687958 Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin Status UNKNOWN Phase PHASE2
NCT02687932 Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation Status COMPLETED Phase PHASE4
NCT02671006 Monitoring Chronic Urticaria Basophil Irritability by Cytometry Status COMPLETED Phase N/A
NCT02662868 Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments Status COMPLETED Phase N/A
NCT02661438 Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo Status COMPLETED Phase NA
NCT02657343 An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. Status COMPLETED Phase PHASE1/PHASE2
NCT02645149 Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT02638909 Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies Status TERMINATED Phase PHASE2
NCT02614508 Buparlisib and Ofatumumab or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Status TERMINATED Phase PHASE1
NCT02607124 A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy Status TERMINATED Phase PHASE1/PHASE2
NCT02605746 Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis Status COMPLETED Phase EARLY_PHASE1
NCT02599129 A Study of Secukinumab for the Treatment of Alopecia Areata Status TERMINATED Phase PHASE2
NCT02598505 Indacaterol in Heart Failure Patients: Any Role on Lung Fluid Regulation Status COMPLETED Phase PHASE3
NCT02592265 Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden Status COMPLETED Phase N/A
NCT02588339 Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention Status COMPLETED Phase PHASE2
NCT02586675 TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer Status COMPLETED Phase PHASE1
NCT02576626 Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD Status COMPLETED Phase PHASE4